Validity of the French form of the somatosensory amplification scale in a non-clinical sample

Bridou, Morgiane; Aguerre, Colette

doi:10.4081/hpr.2013.668

Cited by 9 publications

(6 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The Bodily Distress Syndrome (BDS) Checklist [ 17 ] is another tool comprising 30 items that can be self-administered to screen for somatic symptoms. Other tools that assess the somatic symptoms or can be used as a screening tool for somatization are the Self-reported Somatic Symptom Scale-China (SSS-CN) [ 6 ], the Four-Dimensional Symptom Questionnaire (4-DSQ) [ 20 ], the Central Sensitization Inventory (CSI) [ 7 ], Screening for Somatoform Disorders-7 (SOMS-7 T) [ 10 ], the ICD-10 Symptom List [ 11 ], and the Somatosensory Amplification Scale (SSAS) [ 18 ].…”

Section: Reviewmentioning

confidence: 99%

“…The instrument helps in assessing bodily sensations. The three components gauged using this tool are body hypervigilance, rare and weak body sensations, and emotional reaction to the sensations [ 18 ]. The tool is easy to self-administer and has extremely well-established validity and reliability.…”

Section: Reviewmentioning

confidence: 99%

“…Petersen et al, 2020 [ 17 ] Bodily Distress Syndrome (BDS) Checklist v good v good v good v good v good NA NA NA adequate 15. Bridou et al, 2012 [ 18 ] Somatosensory Amplification Scale (SSAS) v good v good v good v good v good NA NA NA adequate 16. Hançerlioğlu et al, 2019 [ 19 ] Quality of Life in Reflux and Dyspepsia (QOLRAD) Questionnaire adequate adequate v good NA adequate NA NA NA adequate …”

Section: Tablementioning

confidence: 99%

“…Petersen et al, 2020 [ 17 ] Bodily Distress Syndrome (BDS) Checklist NA NA NA NA NA NA NA NA NA NA NA NA NA 15. Bridou et al, 2012 [ 18 ] Somatosensory Amplification Scale (SSAS) NA NA NA v good v good v good v good v good v good v good v good v good v good 16. Hançerlioğlu et al, 2019 [ 19 ] Quality of Life in Reflux and Dyspepsia (QOLRAD) Questionnaire NA NA NA NA NA NA NA NA NA NA NA NA NA …”

Section: Tablementioning

confidence: 99%

See 3 more Smart Citations

Evaluation of Tools to Assess Symptoms and Symptom Severity in Patients With Medically Unexplained Physical Symptoms: A Systematic Review and Narrative Synthesis

Kuanar Baboo,

Ranjan,

Kaur

et al. 2024

Cureus

View full text Add to dashboard Cite

A substantial portion of patients presenting to healthcare settings exhibit physical symptoms lacking clear, demonstrable organic causes. Accurate assessment of symptom severity is crucial for documenting outcomes and establishing treatment efficacy. This systematic review and narrative synthesis aims to provide researchers with insights into available and validated tools for assessing medically unexplained physical symptoms (MUPS). It involved comprehensive searches across electronic databases, including PubMed, Wiley, and Cochrane, adhering to PRISMA and COSMIN guidelines. The study comprised two phases: Phase 1 systematically reviewed tools for assessing MUPS symptoms and severity, while Phase 2 conducted a narrative synthesis of their measurement properties, focusing on validity and reliability. Out of 14,459 records, 191 articles were identified, leading to the recognition of 16 validated tools for assessing MUPS symptoms and severity. Most tools demonstrated excellent internal consistency and structural validity. However, the majority lacked cross-cultural validity. The choice of tools for the assessment of MUPS will assist clinicians and researchers in determining the severity of MUPS and developing a tailored treatment plan to improve the physical and psychological functioning of these patients.

show abstract

Section: Reviewmentioning

confidence: 99%

Section: Reviewmentioning

confidence: 99%

Section: Tablementioning

confidence: 99%

Section: Tablementioning

confidence: 99%

See 2 more Smart Citations

Evaluation of Tools to Assess Symptoms and Symptom Severity in Patients With Medically Unexplained Physical Symptoms: A Systematic Review and Narrative Synthesis

Kuanar Baboo,

Ranjan,

Kaur

et al. 2024

Cureus

View full text Add to dashboard Cite

show abstract

“…The original SSAS has been translated into multiple languages and has shown good internal consistency and test-retest repeatability. 26,33,34 The sum of the 7-items had a total possible score ranging from 7 to 35, where higher scores indicate higher non-noxious somatosensory amplification. Scores were categorized into sex-specific quartiles, as women typically report higher multisensory sensitivity than men, 11,24 enabling high vs low somatosensory amplification comparisons while adjusting for sex differences.…”

Section: Multisensory Sensitivity Assessmentmentioning

confidence: 99%

<p>Multisensory Sensitivity is Related to Deep-Tissue but Not Cutaneous Pain Sensitivity in Healthy Individuals</p>

Wang¹,

Merkle²,

Lee³

et al. 2020

JPR

View full text Add to dashboard Cite

Purpose: Some individuals with chronic pain find daily life sensations (eg, noise, light, or touch) aversive. This amplification of multisensory sensations has been associated with centrally mediated plasticity; for example, greater multisensory sensitivity (MSS) occurs in patients with fibromyalgia than rheumatoid arthritis. However, whether MSS preferentially relates to pain measures which reflect central influences (eg, dynamic quantitative sensory testing (QST) or referred pain), or whether the MSS-pain relationship requires priming from chronic pain, is unknown. Thus, this cross-sectional study investigated the relationships between MSS assessed in a pain-free state and evoked pain sensitivity. Methods: Experimental intramuscular infusion pain and multiple static and dynamic QST were assessed in 465 healthy, pain-free adults: pain thresholds using pressure (PPTs) and heat (HPTs), temporal summation of pain (TSP) using pressure, heat or punctate stimuli, and conditioned pain modulation (CPM) using pressure or heat test stimuli. MSS was assessed using 7 items from Barsky's Somatosensory Amplification Scale. Differences in pain and QST between sex-specific MSS quartiles were assessed, adjusting for multiple comparisons. All participants completed at least one intramuscular infusion condition, but not all were asked to complete each QST (n=166-465). Results: Both static and dynamic QST differed between highest and lowest MSS quartiles using pressure stimuli: lower PPTs (adjusted-p<0.01); increased pressure TSP (adjusted-p=0.02); lower pressure CPM (adjusted-p=0.01). However, none of the heat or punctate QST measures (HPTs, TSP, or CPM) differed between MSS quartiles (adjusted-p>0.05). Odds of experiencing TSP or referred pain was not greater, whereas CPM was 8-fold less likely, in those with highest MSS. Conclusion: Normal variation in non-noxious MSS is related to both static and dynamic pain sensitivity, without sensitization associated with chronic pain, but is dependent on the QST stimulus. Thus, common influences on MSS and pain sensitivity may involve central mechanisms but are likely more complex than previously recognized.

show abstract

Low- and high-anxious hypermobile Ehlers–Danlos syndrome patients: comparison of psychosocial and health variables

et al. 2018

View full text Add to dashboard Cite

Despite the frequent co-ocurrence of hypermobile Ehler-Danlos syndrome (hEDS) and pathological anxiety, little is known about the psychosocial and health implications of such comorbidity. Our aim was to explore the association between high levels of anxiety and psychosocial (catastrophizing, kinesiophobia, somatosensory amplification, social support and functioning), health (pain, fatigue, BMI, tobacco/alcohol use, depression, diagnosis delay, general health), and sociodemographic factors in people with hEDS. In this cross-sectional study, 80 hEDS patients were divided into two groups according to self-reported anxiety levels: low and high. Psychosocial, sociodemographic and health variables were compared between the groups. Forty-one participants reported a high level of anxiety (51.2%). No differences were found in the sociodemographic variables between high-anxious and low-anxious patients. The percentage of participants with severe fatigue and high depressive symptomatology was significantly higher in the high-anxious group (80.5 vs 56.4; 26.8 vs 12.8%, respectively). High-anxious hEDS patients also showed significantly higher levels of pain catastrophizing, somatosensory amplification as well as a poorer social functioning and general health. Multivariate analyses showed that somatosensory amplification, pain catastrophizing and poor social functioning are variables that increase the probability of belonging to the high-anxious group. Despite limitations, this first study comparing high-anxious versus low-anxious hEDS patients with respect to health aspects, highlight the importance of considering the psychosocial factors (many susceptible to modification), to improve the adjustment to this chronic condition and provide support to those affected through a biopsychosocial approach.

show abstract

Validity of the French form of the somatosensory amplification scale in a non-clinical sample

Cited by 9 publications

References 23 publications

Evaluation of Tools to Assess Symptoms and Symptom Severity in Patients With Medically Unexplained Physical Symptoms: A Systematic Review and Narrative Synthesis

Evaluation of Tools to Assess Symptoms and Symptom Severity in Patients With Medically Unexplained Physical Symptoms: A Systematic Review and Narrative Synthesis

<p>Multisensory Sensitivity is Related to Deep-Tissue but Not Cutaneous Pain Sensitivity in Healthy Individuals</p>

Low- and high-anxious hypermobile Ehlers–Danlos syndrome patients: comparison of psychosocial and health variables

Contact Info

Product

Resources

About